I was very impressed with the quarterly. Everything seems to be in place for rapid growth once the Medivet sale is complete. My initial investment thesis is still in play though, if management can't finalise a sale soon it's all for nought.
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game